StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Guided Therapeutics's total debt was $11.00K at Jun 30, 2026. For fiscal 2025 it was $23.00K, down 51.1% from the year before. Over ten years it grew -16.1% a year on average. The highest annual figure on record is $1.39M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.00K-51.1%
FY2024Dec 31, 2024$47.00K–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$17.00K-84.5%
FY2021Dec 31, 2021$110.00K+115.7%
FY2020Dec 31, 2020$51.00K-92.1%
FY2019Dec 31, 2019$646.00K-36.3%
FY2018Dec 31, 2018$1.01M-26.9%
FY2017Dec 31, 2017$1.39M+37.6%
FY2016Dec 31, 2016$1.01M+657.9%
FY2015Dec 31, 2015$133.00K-18.4%
FY2014Dec 31, 2014$163.00K-23.1%
FY2013Dec 31, 2013$212.00K+5200.0%
FY2012Dec 31, 2012$4.00K-84.0%
FY2011Dec 31, 2011$25.00K–
FY2010Dec 31, 2010$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.00K-68.6%
Q1 FY2026Mar 31, 2026$17.00K-58.5%
Q4 FY2025Dec 31, 2025$23.00K-51.1%
Q3 FY2025Sep 30, 2025$29.00K-45.3%
Q2 FY2025Jun 30, 2025$35.00K-40.7%
Q1 FY2025Mar 31, 2025$41.00K–
Q4 FY2024Dec 31, 2024$47.00K–
Q3 FY2024Sep 30, 2024$53.00K–
Q2 FY2024Jun 30, 2024$59.00K–
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$17.00K-84.5%
Q3 FY2022Sep 30, 2022$32.00K+77.8%
Q2 FY2022Jun 30, 2022$47.00K+95.8%
Q1 FY2022Mar 31, 2022$67.00K+31.4%
Q4 FY2021Dec 31, 2021$110.00K+115.7%
Q3 FY2021Sep 30, 2021$18.00K-64.0%
Q2 FY2021Jun 30, 2021$24.00K-52.0%
Q1 FY2021Mar 31, 2021$51.00K-92.1%
Q4 FY2020Dec 31, 2020$51.00K-83.4%
Q3 FY2020Sep 30, 2020$50.00K-95.1%
Q2 FY2020Jun 30, 2020$50.00K-96.4%
Q4 FY2019Dec 31, 2019$646.00K-35.9%
Q1 FY2019Mar 31, 2019$308.00K–
Q4 FY2018Dec 31, 2018$1.01M–
Q4 FY2017Dec 31, 2017$1.39M–
Q4 FY2016Dec 31, 2016$1.01M–

More Guided Therapeutics figures

See a number that looks wrong?